Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: CBD
Ananda Pharma has cleared the final regulatory hurdle needed to begin its ENDOCAN Phase 2 clinical trial, receiving approval from the MHRA and NHS Health Research…
As the founder of 55plus CBD, I’ve seen firsthand how attitudes toward CBD have changed among older adults. What was once met with skepticism is now…
“Republicans, Democrats and independents alike understand that regulation is better than prohibition, and that good science takes time.” By Mike Simpson, Lovewell Farms via Rhode Island…
You might think, “The stronger the product, the better it is.” This narrative is not true. Strong products don’t suit everyone. Each person has unique needs…
CBD, or cannabidiol, has quickly become one of the most talked-about natural compounds in the wellness world. Found in the hemp plant, CBD is known for…
CBD has been used for countering many ailments, be it stress, anxiety, arthritis, chronic pain, epilepsy, and more. People who used CBD managed their problems, but…
CBD products have come a long way from the early days of oils and tinctures. Once limited to a few basic options, the CBD market has…
High-potency CBD products aren’t for everyone. Then, who benefits from high potency CBD products? Let’s explore below. High-potency products like 6500mg are best suited for people…
“Merely hitting pause does not protect public health; thoughtful regulation does.” By Sasha Kalcheff-Korn, Realm of Caring While some policymakers are proposing to delay impending hemp…
The UK’s long-running project to regulate CBD (cannabidiol) products has taken another major step forward, seeing thousands of products make it to the final phase of…
